However, the NORDIC-NEC study ROC analysis suggested that the Ki-67 cut-off of 55% was the most informative with respect to treatment response and prognosis, a position supported by European Neuroendocrine Tumour Society and World Health Organisation (WHO) guidelines [3]. This evidence concerns the gene MKI67 and neoplasm.